CR20210104A - Derivados de heteroarilo bicíclicos - Google Patents

Derivados de heteroarilo bicíclicos

Info

Publication number
CR20210104A
CR20210104A CR20210104A CR20210104A CR20210104A CR 20210104 A CR20210104 A CR 20210104A CR 20210104 A CR20210104 A CR 20210104A CR 20210104 A CR20210104 A CR 20210104A CR 20210104 A CR20210104 A CR 20210104A
Authority
CR
Costa Rica
Prior art keywords
bicyclic heteroaryl
compounds
heteroaryl derivatives
sup
derivatives
Prior art date
Application number
CR20210104A
Other languages
English (en)
Inventor
Jennifer Louise Carter
Hasane Ratni
Original Assignee
Hoffmann La Roche
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hoffmann La Roche filed Critical Hoffmann La Roche
Publication of CR20210104A publication Critical patent/CR20210104A/es

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D498/00Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D498/02Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms in which the condensed system contains two hetero rings
    • C07D498/04Ortho-condensed systems
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D519/00Heterocyclic compounds containing more than one system of two or more relevant hetero rings condensed among themselves or condensed with a common carbocyclic ring system not provided for in groups C07D453/00 or C07D455/00
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/55Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
    • A61K31/553Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole having at least one nitrogen and one oxygen as ring hetero atoms, e.g. loxapine, staurosporine
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/28Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Neurosurgery (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Public Health (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Psychiatry (AREA)
  • Hospice & Palliative Care (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)

Abstract

<p>La invención proporciona nuevos compuestos heteroarilo bicíclicos que presentan la Fórmula general (I)</p> <p><img src="data:image/png;base64,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 (***)
CR20210104A 2018-09-03 2019-09-02 Derivados de heteroarilo bicíclicos CR20210104A (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP18192219 2018-09-03
PCT/EP2019/073303 WO2020048904A1 (en) 2018-09-03 2019-09-02 Bicyclic heteroaryl derivatives

Publications (1)

Publication Number Publication Date
CR20210104A true CR20210104A (es) 2021-04-19

Family

ID=63490310

Family Applications (1)

Application Number Title Priority Date Filing Date
CR20210104A CR20210104A (es) 2018-09-03 2019-09-02 Derivados de heteroarilo bicíclicos

Country Status (31)

Country Link
US (1) US12084461B2 (es)
EP (1) EP3846903B1 (es)
JP (1) JP7398435B2 (es)
KR (1) KR20210054515A (es)
CN (1) CN112566696B (es)
AR (1) AR116051A1 (es)
AU (1) AU2019336492A1 (es)
BR (1) BR112021002170A2 (es)
CA (1) CA3107593A1 (es)
CL (1) CL2021000486A1 (es)
CO (1) CO2021002415A2 (es)
CR (1) CR20210104A (es)
DK (1) DK3846903T3 (es)
ES (1) ES2966947T3 (es)
FI (1) FI3846903T3 (es)
HR (1) HRP20231663T1 (es)
HU (1) HUE064554T2 (es)
IL (1) IL281175B2 (es)
LT (1) LT3846903T (es)
MA (1) MA53541B1 (es)
MX (1) MX2021002087A (es)
PE (1) PE20210860A1 (es)
PH (1) PH12021550320A1 (es)
PL (1) PL3846903T3 (es)
PT (1) PT3846903T (es)
RS (1) RS64950B1 (es)
SG (1) SG11202102137SA (es)
SI (1) SI3846903T1 (es)
TW (1) TWI841592B (es)
UA (1) UA128482C2 (es)
WO (1) WO2020048904A1 (es)

Family Cites Families (28)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5994349A (en) 1997-10-27 1999-11-30 Howard University 3-carboalkoxy-2, 3-dihydro-1H-phenothiazin-4[10H]-one derivatives
CA2326777C (en) 1998-04-01 2011-12-20 Nortran Pharmaceuticals Inc. Aminocyclohexyl ether compounds and uses thereof
AU2528900A (en) 1999-02-12 2000-08-29 Nortran Pharmaceuticals Inc. Cycloalkyl amine compounds and uses thereof
US7507545B2 (en) 1999-03-31 2009-03-24 Cardiome Pharma Corp. Ion channel modulating activity method
WO2000071528A1 (en) 1999-05-25 2000-11-30 Neurogen Corporation 4h-1,4-benzothiazine-2-carboxamides and their use as gaba brain receptor ligands
EP1218003A4 (en) 1999-09-13 2004-02-11 David M Swope COMPOSITION AND METHOD FOR REDUCING NEUROLOGICAL SYMPTOMATOLOGY
US7057053B2 (en) 2000-10-06 2006-06-06 Cardiome Pharma Corp. Ion channel modulating compounds and uses thereof
WO2007032009A2 (en) 2005-09-15 2007-03-22 Biomas Ltd. Use of tellurium compounds for treatment of basal cell carcinoma and/or actinic keratosis
JP5264890B2 (ja) 2007-05-11 2013-08-14 エフ.ホフマン−ラ ロシュ アーゲー アミロイドベータの調節剤としてのヘタリールアニリン
MX2010004309A (es) 2007-10-19 2010-05-03 Janssen Pharmaceutica Nv Moduladores de piperidinil y piperazinil de gamma-secretasa.
WO2010056849A1 (en) 2008-11-13 2010-05-20 Schering Corporation Gamma secretase modulators
JP2012519152A (ja) 2009-02-26 2012-08-23 エーザイ・アール・アンド・ディー・マネジメント株式会社 含窒素縮合複素環化合物及びベータアミロイド産生阻害剤としてのその使用
WO2010138901A1 (en) 2009-05-29 2010-12-02 Biogen Idec Ma Inc Carboxylic acid-containing compounds, derivatives thereof, and related methods of use
CA2767764A1 (en) * 2009-07-13 2011-01-20 Takeda Pharmaceutical Company Limited Heterocyclic compound and use thereof
EP2443657A4 (en) 2009-09-04 2013-07-31 Hewlett Packard Development Co MEMORISTS BASED ON METALLIC COMPOUNDS WITH MIXED VALENCIES
US20110190269A1 (en) 2010-02-01 2011-08-04 Karlheinz Baumann Gamma secretase modulators
US8486967B2 (en) 2010-02-17 2013-07-16 Hoffmann-La Roche Inc. Heteroaryl substituted piperidines
US8703763B2 (en) 2011-03-02 2014-04-22 Hoffmann-La Roche Inc. Bridged piperidine derivatives
AU2012285931B2 (en) 2011-07-15 2017-01-12 Cellzome Limited Novel substituted indole derivatives as gamma secretase modulators
WO2014060112A1 (en) 2012-10-19 2014-04-24 Origenis Gmbh Pyrazolo[4,3-d]pyrimidines as kinase inhibitors
WO2017042114A1 (en) 2015-09-09 2017-03-16 F. Hoffmann-La Roche Ag Bridged piperidine derivatives
JP6872550B2 (ja) 2015-12-10 2021-05-19 エフ.ホフマン−ラ ロシュ アーゲーF. Hoffmann−La Roche Aktiengesellschaft 架橋されたピペリジン誘導体
WO2018001918A1 (en) 2016-06-27 2018-01-04 F. Hoffmann-La Roche Ag Triazolopyridines as gamma-secretase modulators
AR109829A1 (es) 2016-09-29 2019-01-30 Hoffmann La Roche Derivados de piperidina puenteados
WO2018083050A1 (en) 2016-11-01 2018-05-11 F. Hoffmann-La Roche Ag Bicyclic heteroaryl derivatives
JP7132218B2 (ja) 2016-11-08 2022-09-06 エフ.ホフマン-ラ ロシュ アーゲー フェノキシトリアゾール
RU2757276C2 (ru) 2016-12-16 2021-10-12 Пайплайн Терапьютикс, Инк. Способы лечения кохлеарной синаптопатии
CN111417636B (zh) 2018-01-22 2023-09-26 豪夫迈·罗氏有限公司 三唑并-氮杂䓬衍生物

Also Published As

Publication number Publication date
BR112021002170A2 (pt) 2021-05-04
HUE064554T2 (hu) 2024-03-28
WO2020048904A1 (en) 2020-03-12
IL281175A (en) 2021-04-29
AU2019336492A1 (en) 2021-01-07
PH12021550320A1 (en) 2021-10-04
PE20210860A1 (es) 2021-05-18
SG11202102137SA (en) 2021-04-29
FI3846903T3 (fi) 2023-12-19
MX2021002087A (es) 2021-04-28
LT3846903T (lt) 2024-01-10
CN112566696A (zh) 2021-03-26
HRP20231663T1 (hr) 2024-03-15
IL281175B1 (en) 2023-09-01
CA3107593A1 (en) 2020-03-12
CN112566696B (zh) 2024-01-16
JP7398435B2 (ja) 2023-12-14
CO2021002415A2 (es) 2021-03-08
SI3846903T1 (sl) 2024-02-29
IL281175B2 (en) 2024-01-01
US12084461B2 (en) 2024-09-10
PT3846903T (pt) 2023-12-14
KR20210054515A (ko) 2021-05-13
JP2021535178A (ja) 2021-12-16
RS64950B1 (sr) 2024-01-31
MA53541B1 (fr) 2024-02-29
DK3846903T3 (da) 2024-01-02
EP3846903A1 (en) 2021-07-14
US20210323980A1 (en) 2021-10-21
TW202023649A (zh) 2020-07-01
CL2021000486A1 (es) 2021-07-30
EP3846903B1 (en) 2023-10-25
UA128482C2 (uk) 2024-07-24
ES2966947T3 (es) 2024-04-25
PL3846903T3 (pl) 2024-05-06
AR116051A1 (es) 2021-03-25
MA53541A (fr) 2021-12-08
TWI841592B (zh) 2024-05-11

Similar Documents

Publication Publication Date Title
CR20210247A (es) Nuevos compuestos heterocíclicos
MX2021002978A (es) Lactamas biciclicas y metodos de uso de las mismas.
PH12021500014A1 (en) Fused ring compounds
WO2020097537A3 (en) Fused ring compounds
WO2020243415A3 (en) Tead inhibitors and uses thereof
MX2021001433A (es) Nuevos compuestos heterociclicos como inhibidores de la monoacilglicerol lipasa.
WO2018195397A3 (en) Indole ahr inhibitors and uses thereof
WO2017050791A8 (en) New bicyclic compounds as dual atx/ca inhibitors
PH12018502535B1 (en) Substituted carbonucleoside derivatives useful as anticancer agents
MX2020009234A (es) Compuestos de heteroarilo como inhibidores de cinasas asociadas con receptores de interleucina-1 (irak) tipo ii y usos de los mismos.
PH12020500105A1 (en) Bicyclic ketone compounds and methods of use thereof
CR20220116A (es) Compuestos heterocíclicos
CR20220004A (es) Nuevos compuestos heterocíclicos
ZA202309446B (en) Rapamycin analogs and uses thereof
MX2022002831A (es) Compuestos heterociclicos.
MX2023002224A (es) Compuestos heterociclicos.
MX2020002449A (es) Nuevos compuestos heterociclicos fungicidas.
MX2020006370A (es) Pirazolopiridina-diamidas, su uso como insecticida y procesos para prepararlas.
MX2023008634A (es) Análogos de rapamicina y usos de estos.
MX2021001904A (es) Formas solidas de benzoxaborol sustituido y composiciones de las mismas.
WO2018166993A3 (en) PYRAZOLOCHLOROPHENYL COMPOUNDS, COMPOSITIONS AND METHODS OF USE THEREOF
WO2020139971A3 (en) Methods for making dimeric naphthalimides and solid state forms of the same
MX2021005535A (es) Compuestos antibióticos, métodos de fabricacion de los mismos, composiciones farmacéuticas contienendo los mismos y usos de los mismos.
CR20210104A (es) Derivados de heteroarilo bicíclicos
WO2020198567A8 (en) Quinoline derivatives and their use for the treatment of cancer